selected publications
-
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.
Alzheimer disease and associated disorders.
2013
Academic Article
GET IT
Times cited: 30 -
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).
Alzheimer's & dementia : the journal of the Alzheimer's Association.
2012
Review
GET IT
Times cited: 34 -
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Human molecular genetics.
2012
Academic Article
GET IT
Times cited: 149 -
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.
Journal of the American Academy of Dermatology.
2003
Conference Paper
GET IT
Times cited: 829